Anti-Bacterial Agents Clinical Trial
Official title:
Effect of Antibiotic Treatment Course on Clinical Outcome After Two-stage Revision of Prosthetic Joint Infection: A Prospective Cohort Study.
This is a multicenter prospective cohort study in which patients were evaluated by inclusion and exclusion criteria before phase II revision surgery. Eligible patients will be included in this study after signing the informed consent form. After the second stage revision, according to the patient's symptoms and examination results, the attending physician used a reasonable antibiotic treatment scheme (including intravenous and oral medication). All patients voluntarily participated in the study and signed informed consent. During the treatment period, all prospective patients underwent clinical evaluation at the time points of 1, 3, 6, 12, 18 and 24 months after the start of antibiotic treatment after phase II revision. The infection control rate of patients was evaluated by follow-up at least 2 years after operation, so as to analyze the effect of antibiotic treatment course after two-stage revision of periprosthetic joint infection.
Inclusion criteria： 1. A diagnosis of PJI was made according to MSIS criteria 2. Received spacer implantation and a full course of antibiotic treatment (at least 6 weeks), the patient was clinically determined to have infection control and underwent secondary joint revision. 3. Age ≥18 years old 4. The patient voluntarily participated in the study, and was physically and mentally tolerant to the treatment process and various tests of the study. He has signed an informed consent form and passed the examination of all the hospital ethics committees participating in the study. Exclusion criteria： 1. Follow up data were not available; 2. The investigator judged that the patient no longer met the criteria of the study due to compliance problems. Recruiting time：2021.10 -2023.10.31 Interventions Group：No Sample size：500 Study Population Description: Patients who underwent secondary replantation surgery for prosthetic joint infection at the First Affiliated Hospital of Fujian Medical University and other sub-centers were selected. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05846399 -
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
|
Phase 4 | |
| Completed |
NCT03349567 -
Improving Antimicrobial-Prescribing in Emergency Departments
|
N/A | |
| Completed |
NCT04172207 -
Antibiotic, Gingival-biopsy, and Oral-smear Samples.
|
||
| Completed |
NCT05261152 -
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
|
Phase 4 | |
| Terminated |
NCT03089697 -
Phase IIa Clinical Study of N-Rephasin® SAL200
|
Phase 2 | |
| Completed |
NCT03037112 -
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
|
N/A | |
| Recruiting |
NCT03440216 -
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
|
N/A | |
| Completed |
NCT03408457 -
Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections
|
||
| Completed |
NCT04872400 -
Acute Application of Antibiotic Powder in Open Fracture Wounds
|
Phase 4 | |
| Completed |
NCT03114358 -
Carbapenems De-escalation as Antimicrobial Stewardship
|
N/A | |
| Completed |
NCT03245879 -
Antibiotic Stewardship in Small Hospitals
|
N/A | |
| Recruiting |
NCT05925309 -
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
|
N/A | |
| Completed |
NCT03098485 -
Healthy Patients & Effect of Antibiotics
|
N/A | |
| Completed |
NCT00272155 -
An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice
|
Phase 1/Phase 2 | |
| Completed |
NCT03280147 -
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
|
Phase 3 | |
| Completed |
NCT04713436 -
The Effects of Antibiotic Combinations on Stem Cells
|
||
| Completed |
NCT03446053 -
A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT04210713 -
Neuroimmune Dysfunction in Alcohol Use Disorder
|
Phase 1 | |
| Recruiting |
NCT05132829 -
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
|
Phase 4 | |
| Completed |
NCT01855048 -
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers
|
Phase 1 |